Percutaneous Transluminal Coronary Angioplasty (PTCA) procedures are commonly performed in the United States (US) for the invasive management of coronary artery disease (CAD). Because of the relative expense and frequency of PTCA and increasingly elderly US population, the annual health care expenditure for PTCA is significant and will continue to expand. The clinical indications for PTCA have been fairly well-established. Our study tested the hypothesis that the incidence of PTCA per State was constant. We examined the 1992 PTCA database from the Health Care Financing Administration (HCFA) which included procedure volume for 805 US hospitals performing PTCA on Medicare patients and was aggregated by State. Population data for age >65 wa...